Vaccination contre la COVID-19 des patients atteints de cancer solide : revue et préconisations d’un inter-groupe oncologique français (CGO, TNCD, UNICANCER) [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]

Details

Serval ID
serval:BIB_7ED320B63D3A
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Vaccination contre la COVID-19 des patients atteints de cancer solide : revue et préconisations d’un inter-groupe oncologique français (CGO, TNCD, UNICANCER) [Vaccination against COVID-19 in patients with solid cancer: Review and point of view from a French oncology inter-group (CGO, TNCD, UNICANCER)]
Journal
Bulletin du cancer
Author(s)
Tougeron D., Seitz-Polski B., Hentzien M., Bani-Sadr F., Bourhis J., Ducreux M., Gaujoux S., Gorphe P., Guiu B., Hardy-Bessard A.C., Hoang Xuan K., Huguet F., Lecomte T., Lièvre A., Louvet C., Maggiori L., Mariani P., Michel P., Servettaz A., Thariat J., Westeel V., Aparicio T., Blay J.Y., Bouché O.
Working group(s)
Thésaurus national de cancérologie digestive (TNCD), réseau de groupes coopérateurs en oncologie (GCO), Fédération nationale des centres de lutte contre le cancer (UNICANCER), association de chirurgie hépato-bilio-pancréatique et transplantation (ACHBT), association de recherche sur les cancers gynecologiques-groupes d'investigateurs nationaux pour l'étude des cancers ovariens et du sein (ARCAGY-GINECO), Fédération francophone de cancérologie digestive (FFCD), groupe coopérateur multidisciplinaire en oncologie (GERCOR), groupe d'oncologie radiothérapie tête et cou-intergroupe ORL (GORTEC-Intergroupe ORL), intergroupe francophone de cancérologie thoracique (IFCT), intergroupe coopérateur de neuro-oncologie association des neuro-oncologues d'expression française (IGCNO-ANOCEF), Société française de chirurgie digestive (SFCD), Société française d'endoscopie digestive (SFED), Société française de radiothérapie oncologique (SFRO), Société française de radiologie (SFR), Société nationale française de colo-proctologie (SNFCP), Société nationale française de gastroentérologie (SNFGE)
ISSN
1769-6917 (Electronic)
ISSN-L
0007-4551
Publication state
Published
Issued date
06/2021
Peer-reviewed
Oui
Volume
108
Number
6
Pages
614-626
Language
french
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Abstract
The COVID-19 pandemic has a major impact at all stages of cancer treatment. Risk of death from COVID-19 in patients treated for a cancer is high. COVID-19 vaccines represent a major issue to decrease the rate of severe forms of the COVID-19 cases and to maintain a normal cancer care. It is difficult to define the target population for vaccination due to the limited data available and the lack of vaccine doses available. It appears theoretically important to vaccinate patients with active cancer treatment or treated since less than three years, as well as their family circle. In France, patients actually defined at "high risk" for priority access to vaccination are those with a cancer treated by chemotherapy. A panel of experts recently defined another "very high-priority" population, which includes patients with curative or palliative first or second-line chemotherapy, as well as patients requiring surgery or radiotherapy involving a large lung volume, lymph nodes and/or of hematopoietic tissue. Ideally, it is best to vaccinate before cancer treatment. Despite the lack of published data, COVID-19 vaccines can also be performed during chemotherapy by avoiding periods of bone marrow aplasia and if possible, to do it in cancer care centers. It is necessary to implement cohorts with immunological and clinical monitoring of vaccinated cancer patients. To conclude, considering the current state of knowledge, the benefit-risk ratio strongly favours COVID-19 vaccination of all cancer patients.
Keywords
COVID-19/epidemiology, COVID-19/immunology, COVID-19/prevention & control, COVID-19 Vaccines/administration & dosage, COVID-19 Vaccines/adverse effects, COVID-19 Vaccines/immunology, COVID-19 Vaccines/supply & distribution, Contraindications, France/epidemiology, Humans, Immunotherapy, Adoptive, Molecular Targeted Therapy, Neoplasms/immunology, Neoplasms/therapy, Pandemics, Vaccination, COVID-19, Cancers solides, Chemotherapy, Chimiothérapie, Coronavirus, Radiotherapy, Radiothérapie, Solid cancers
Pubmed
Web of science
Open Access
Yes
Create date
11/05/2021 8:35
Last modification date
13/10/2021 5:43
Usage data